首页 | 本学科首页   官方微博 | 高级检索  
     


Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls
Authors:H Beckmann  R E Lang  W F Gattaz
Affiliation:1. Central Institute of Mental Health, Mannheim, Federal Republic of Germany.;2. Institute of Pharmacology of the University Heidelberg, Federal Republic of Germany.
Abstract:Vasopressin and oxytocin seem to be involved in the processes of learning and memory in animals and probably in man. These peptides appear to have opposite effects in that vasopressin improves memory processes and oxytocin produces amnestic effects. We measured these neuropeptides in the cerebrospinal fluid of schizophrenic patients with and without neuroleptic treatment, psychiatrically healthy controls and drug-free patients before and after three weeks' neuroleptic treatment. There were no significant differences in vasopressin concentrations between schizophrenics and controls. No influence of neuroleptic treatment on vasopressin concentrations was detected. In contrast, concentrations of oxytocin were increased in all schizophrenic patients and were higher in those receiving neuroleptic treatment. In addition, oxytocin concentrations increased after three weeks' neuroleptic treatment. Drug-induced increase of oxytocin concentrations may be of significance in the clinically observed amnestic syndromes and debilitation in schizophrenics treated with neuroleptics.
Keywords:Vasopressin  oxytocin  cerebrospinal fluid  neuroleptics  schizophrenic patients
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号